Correlation Between Elevation Oncology and Relay Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Elevation Oncology and Relay Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Elevation Oncology and Relay Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Elevation Oncology and Relay Therapeutics, you can compare the effects of market volatilities on Elevation Oncology and Relay Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Elevation Oncology with a short position of Relay Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Elevation Oncology and Relay Therapeutics.

Diversification Opportunities for Elevation Oncology and Relay Therapeutics

0.06
  Correlation Coefficient

Significant diversification

The 3 months correlation between Elevation and Relay is 0.06. Overlapping area represents the amount of risk that can be diversified away by holding Elevation Oncology and Relay Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Relay Therapeutics and Elevation Oncology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Elevation Oncology are associated (or correlated) with Relay Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Relay Therapeutics has no effect on the direction of Elevation Oncology i.e., Elevation Oncology and Relay Therapeutics go up and down completely randomly.

Pair Corralation between Elevation Oncology and Relay Therapeutics

Given the investment horizon of 90 days Elevation Oncology is expected to generate 1.79 times more return on investment than Relay Therapeutics. However, Elevation Oncology is 1.79 times more volatile than Relay Therapeutics. It trades about 0.13 of its potential returns per unit of risk. Relay Therapeutics is currently generating about -0.27 per unit of risk. If you would invest  57.00  in Elevation Oncology on September 1, 2024 and sell it today you would earn a total of  7.00  from holding Elevation Oncology or generate 12.28% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Elevation Oncology  vs.  Relay Therapeutics

 Performance 
       Timeline  
Elevation Oncology 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Elevation Oncology has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's technical and fundamental indicators remain stable and the latest fuss on Wall Street may also be a sign of long-term gains for the venture sophisticated investors.
Relay Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Relay Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of conflicting performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.

Elevation Oncology and Relay Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Elevation Oncology and Relay Therapeutics

The main advantage of trading using opposite Elevation Oncology and Relay Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Elevation Oncology position performs unexpectedly, Relay Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Relay Therapeutics will offset losses from the drop in Relay Therapeutics' long position.
The idea behind Elevation Oncology and Relay Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.

Other Complementary Tools

Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Fundamental Analysis
View fundamental data based on most recent published financial statements
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume